Drug Profile
Research programme: pandemic influenza vaccine adjuvants - IDRI/PATH
Alternative Names: Pandemic influenza vaccine adjuvants - IDRI/PATHLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Infectious Disease Research Institute; PATH
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Influenza-virus-infections(Adjuvant therapy) in USA
- 25 Jun 2010 Early research in Influenza virus infections in USA (unspecified route)